Gyre Therapeutics, Inc. Balance Sheet

Balance Sheet Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 319.38M262.79M258.13M189.58M145.87M2.98M69.52M38.09M39.51M124.92M94.85M55.66M84.75M116.54M125.41M
Current Assets
Cash & Equivalents 83.91M165.85M107.28M3.40M2.83M1.54M29.10M36.55M37.64M119.05M81.90M46.85M25.18M33.51M11.81M
Short-term Investments 27.16M48.17M87.72M42.72M37.84M0.28M3.40M19.47M17.97M88.91M48.99M2.50M14.90M
Cash & Current Investments 111.07M214.02M195.00M46.12M40.67M1.82M32.50M56.02M55.61M207.97M130.89M49.35M25.18M33.51M26.71M
Receivables - Net 0.27M0.84M0.22M1.38M0.28M0.10M0.49M0.03M0.02M0.01M3.31M1.82M17.14M15.55M23.96M
Receivables - Other 1.05M0.18M0.01M4.96M
Receivables 0.27M0.84M0.22M2.43M0.46M0.11M0.49M0.03M0.02M0.01M3.31M1.82M17.14M15.55M28.92M
Raw Materials 1.06M0.92M0.79M
Work In Process 3.67M2.00M2.93M
Finished Goods 1.40M1.36M2.61M
Inventory 6.12M4.28M6.34M
Prepaid Assets 1.56M3.22M3.00M1.40M1.00M0.10M1.78M0.96M1.33M3.81M6.84M2.81M0.84M1.55M2.62M
Current Assets 314.43M218.08M198.22M127.74M93.61M2.07M68.70M37.52M39.11M123.99M89.51M51.48M49.65M57.22M64.79M
Non-Current Assets
Buildings 1.13M1.18M
Property, Plant & Equipment (Net) 4.78M6.07M5.04M1.64M0.68M0.91M0.70M0.44M0.28M0.39M0.43M0.97M17.71M23.29M23.88M
Long-Term Investments 38.49M54.27M59.97M51.45M3.42M2.54M40.63M49.71M
Intangibles 0.17M0.15M0.30M0.30M0.30M0.30M2.04M0.60M0.70M
Goodwill & Intangibles 0.17M0.15M0.30M0.30M0.30M0.30M2.04M0.60M0.70M
Long-Term Deferred Tax 75.48M75.83M4.08M4.70M5.62M
Other Non-Current Assets 0.48M0.12M0.04M0.01M0.12M0.12M0.13M0.54M0.53M0.47M3.39M0.99M6.28M
Non-Current Assets 4.95M44.71M59.91M61.84M52.27M0.91M0.82M0.57M0.40M0.93M5.34M4.19M35.10M59.32M60.62M
Liabilities
Current Liabilities
Accounts Payables 1.27M4.72M3.49M2.06M1.30M0.25M0.94M0.84M0.75M1.25M5.93M6.42M0.12M0.35M0.11M
Notes Payables 33.74M19.40M5.08M
Dividends payables 7.56M
Payables 1.27M4.72M3.49M2.06M1.30M0.25M34.68M20.24M5.83M1.25M5.93M6.42M7.68M0.35M0.11M
Accumulated Expenses 5.27M10.52M16.17M6.08M8.83M0.28M0.93M0.60M1.37M1.50M2.48M1.47M9.26M11.94M10.62M
Other Accumulated Expenses 0.13M0.06M0.05M0.03M0.54M0.81M1.32M2.04M6.74M4.07M0.12M1.37M0.23M
Short term Debt 1.44M1.71M1.24M0.85M0.85M1.16M
Current Leases 0.66M1.98M0.49M0.21M0.71M
Current Taxes 2.10M5.05M2.83M
Current Deferred Revenue 0.47M81.71M57.71M2.36M1.75M0.44M0.28M0.21M0.01M1.98M0.23M0.14M0.04M0.06M
Total Current Liabilities 101.23M98.66M78.61M11.35M10.98M2.34M37.76M21.96M8.74M4.80M17.80M14.16M12.24M20.05M19.52M
Non-Current Liabilities
Non-Current Debt 1.97M1.35M1.99M1.14M0.28M
Non-Current Deffered Revenue 147.19M70.93M3.24M1.18M0.73M0.29M0.05M0.17M0.12M0.21M0.93M
Preferred Stock Liabilities 98.90M104.64M108.88M33.31M64.53M
Minority Interest 29.70M29.78M35.08M
Non-Current Deferred Tax Liability 2.50M8.30M
Operating Leases 0.98M0.41M0.12M0.20M0.89M
Other Non-Current Liabilities 0.39M1.16M0.06M17.56M10.63M
Total Non-Current Liabilities 3.06M36.94M12.48M20.51M16.38M
Liabilities
Total Liabilities 250.39M170.94M83.84M13.66M11.26M3.46M38.10M22.02M8.74M4.97M18.78M14.57M12.54M38.06M27.00M
Shareholder's Equity
Total Debt 3.41M3.06M3.23M1.99M1.14M1.16M
Common Equity 68.99M91.85M174.29M-93.34M-103.01M-109.35M31.43M16.07M30.98M119.94M76.07M41.09M72.22M-15.83M98.40M
Shareholder's Equity 68.99M91.85M174.29M-93.34M-103.01M-109.35M31.43M16.07M30.98M119.94M76.07M41.09M72.22M-15.83M98.40M
Liabilities and Shareholders Equity 319.38M262.79M258.13M189.58M145.87M2.98M69.52M38.09M39.51M124.92M94.85M55.66M84.75M116.54M125.41M
Retained Earnings -229.30M-218.40M-226.93M-233.93M-280.63M-116.28M-131.04M-147.98M-173.49M-203.34M-314.76M-402.69M7.39M-85.54M-73.45M
Treasury Shares 1.38M1.57M1.36M0.51M0.10M0.14M0.82M